GLP-1 drugs are such money makers that it's worth advertising them so that you 1) know they exist 2) might recommend them 3) might take them yourself at some po

GLP-1 drugs are such money makers that it's worth advertising them so that you 1) know they exist 2) might recommend them 3) might take them yourself at some point. A month's supply of Wegovy/etc costs nearly $2k. Same thing with the monoclonal antibody drugs, you can be looking at tens of thousands of dollars per month for a single patient. You also see this with luxury brands, that advertise to segments that cannot afford their products, in order to build image of luxury and prestige. That said, I asked my friends/family if they had <not embarrassing or too intrusive> condition, and more often than not, someone in the household had it.